9 Recruiting Studies Using Canakinumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Canakinumab
Canakinumab With Darbepoetin Alfa in PTs With Lower-Risk MDS Who Have Failed ESA
📍 Moffitt Cancer Center — Tampa, Florida
Myelodysplastic Syndromes
View Study & Checklist ➔A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer
📍 Ambulatory Care Center — New York, New York
Pancreatic Cancer
View Study & Checklist ➔Study of Canakinumab in Patients With Myelofibrosis
📍 Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute — Los Angeles, California
Primary Myelofibrosis
View Study & Checklist ➔Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
📍 University of Massachusetts Chan Medical School — Worcester, Massachusetts
Skin Inflammation
View Study & Checklist ➔Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
📍 M D Anderson Cancer Center — Houston, Texas
Lung Carcinoma
View Study & Checklist ➔Effects of IL-1 Beta Inhibition on Vascular Inflammation in TET2 Clonal Hematopoiesis
📍 Massachusetts General Hospital — Boston, Massachusetts
Vascular Inflammation
View Study & Checklist ➔Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
📍 University of Miami — Miami, Florida
Clonal Cytopenia of Undetermined Significance
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔A Phase II, Open-Label, Study of Subcutaneous Canakinumab, an Anti-IL-1β Human Monoclonal Antibody, for Patients With Low or Int-1 Risk IPSS/IPSS-R Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia
📍 M D Anderson Cancer Center — Houston, Texas
Chronic Myelomonocytic Leukemia
View Study & Checklist ➔